Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History LXRX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics LXRX

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Lexicon Pharmaceuticals Inc

LXRX
Current price
0.73 USD +0.011 USD (+1.49%)
Last closed 0.75 USD
ISIN US5288723027
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 272 383 488 USD
Yield for 12 month -59.44 %
1Y
3Y
5Y
10Y
15Y
LXRX
21.11.2021 - 28.11.2021

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. The company offers Sotagliflozin, an orally-delivered small molecule drug to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visits in adults with heart failure or type 2 diabetes mellitus, chronic kidney disease or CKD, and other cardiovascular risk factors. Its orally-delivered small molecule drug candidates under development include sotagliflozin for the treatment of hypertrophic cardiomyopathy or HCM and type 1 diabetes that is in Phase 3 clinical trial; LX9211, which has completed Phase II clinical trials for the treatment of neuropathic pain; and LX9851 for the treatment of obesity and associated cardiometabolic disorders, as well as for weight management. Lexicon Pharmaceuticals, Inc. has strategic collaboration and license agreements with Viatris Inc. and Bristol-Myers Squibb Company. The company was incorporated in 1995 and is headquartered in The Woodlands, Texas. Address: 2445 Technology Forest Boulevard, The Woodlands, TX, United States, 77381

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

2.58 USD

P/E ratio

Dividend Yield

Financials LXRX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures LXRX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+31 081 000 USD

Last Year

+1 204 000 USD

Current Quarter

+1 262 000 USD

Last Quarter

+26 554 000 USD

Current Year

+30 465 000 USD

Last Year

+1 119 000 USD

Current Quarter

+1 232 000 USD

Last Quarter

+26 206 000 USD
EBITDA -164 596 992 USD
Operating Margin TTM -2 034.79 %
Price to Earnings
Return On Assets TTM -28.88 %
PEG Ratio -0.14
Return On Equity TTM -86.09 %
Wall Street Target Price 2.58 USD
Revenue TTM 31 213 000 USD
Book Value 0.34 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 11.70 %
Dividend Yield
Gross Profit TTM -52 762 000 USD
Earnings per share -0.50 USD
Diluted Eps TTM -0.50 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY -63.40 %
Profit Margin

Stock Valuation LXRX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 4.81
Price Sales TTM 7.81
Enterprise Value EBITDA -2.58
Price Book MRQ 1.98

Technical indicators LXRX

For 52 weeks

0.28 USD 2.45 USD
50 Day MA 0.64 USD
Shares Short Prior Month 43 028 675
200 Day MA 0.92 USD
Short Ratio 9.40
Shares Short 38 825 388
Short Percent 29.88 %